# Timothy Kubal

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/timothy-kubal/

## Facts

| Field | Value |
| --- | --- |
| Citations | 772 |
| Field | Economic and Financial Impacts of Cancer |
| h-index | 10 |
| i10-index | 10 |
| Last Known Institution | Moffitt Cancer Center |
| OpenAlex ID | https://openalex.org/A5043454140 |
| Works | 48 |

## Researcher papers

- [Rosai-Dorfman Disease: Tumor Biology, Clinical Features, Pathology, and Treatment](https://scholariq.org/papers/rosai-dorfman-disease-tumor-biology-clinical-features-pathology-and-treatment/)
- [Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/cancer-associated-venous-thromboembolic-disease-version-2-2024-nccn-clinical/)
- [Safety at the Time of the COVID-19 Pandemic: How to Keep Our Oncology Patients and Healthcare Workers Safe](https://scholariq.org/papers/safety-at-the-time-of-the-covid-19-pandemic-how-to-keep-our-oncology-patients/)
- [Recurrent excitation in the dentate gyrus of a murine model of temporal lobe epilepsy](https://scholariq.org/papers/recurrent-excitation-in-the-dentate-gyrus-of-a-murine-model-of-temporal-lobe/)
- [Prospective <i>CYP2C19</i>‐Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations](https://scholariq.org/papers/prospective-i-cyp2c19-i-guided-voriconazole-prophylaxis-in-patients-with/)
- [National Comprehensive Cancer Network Infusion Efficiency Workgroup Study: Optimizing Patient Flow in Infusion Centers](https://scholariq.org/papers/national-comprehensive-cancer-network-infusion-efficiency-workgroup-study/)
- [Teaching Diversity and Learning Outcomes: Bringing Lived Experience into the Classroom](https://scholariq.org/papers/teaching-diversity-and-learning-outcomes-bringing-lived-experience-into-the/)
- [Longitudinal cohort study to determine effectiveness of a novel simulated case and feedback system to improve clinical pathway adherence in breast, lung and GI cancers](https://scholariq.org/papers/longitudinal-cohort-study-to-determine-effectiveness-of-a-novel-simulated-case/)
- [Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double‐induction chemotherapy: Analysis from a large, single institution experience](https://scholariq.org/papers/bone-marrow-cellularity-at-day-14-is-the-most-important-predictive-factor-for/)
- [Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer.](https://scholariq.org/papers/budget-impact-of-adaptive-abiraterone-therapy-for-castration-resistant-prostate/)
- [Cutaneous Reactions to Iron Infusions: A Case Report and Clinical Review](https://scholariq.org/papers/cutaneous-reactions-to-iron-infusions-a-case-report-and-clinical-review/)

## Researcher topics

- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Clinical practice guidelines implementation](https://scholariq.org/topics/clinical-practice-guidelines-implementation/)

## Researcher university

- [Moffitt Cancer Center](https://scholariq.org/institutions/moffitt-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.